Extrapancreatic effect of somatostatin infusion to increase glucose clearance (Q48631132)

13 February 2018

title

Extrapancreatic effect of somatostatin infusion to increase glucose clearance (English)

1 reference

13 February 2018

author name string

R N Bergman

1 reference

13 February 2018

M Ader

1 reference

13 February 2018

D T Finegood

1 reference

13 February 2018

G Pacini

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 September 1984

1 reference

13 February 2018

American Journal of Physiology

published in

1 reference

13 February 2018

volume

247

1 reference

13 February 2018

issue

3 Pt 1

1 reference

13 February 2018

page(s)

E370-9

1 reference

13 February 2018

Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Effect of glucagon on glucose production during insulin deficiency in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Relationship between the plasma glucose level and glucose uptake in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: Studies with somatostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Integrated concentration of growth hormone in juvenile-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

A Simplified Method Using Somatostatin to Assess In Vivo Insulin Resistance over a Range of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Studies on the inhibition of insulin release, glycogenolysis and gluconeogenesis by somatostatin in the rat islets of langerhans and isolated hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

A minimal-model-based glucose clamp yielding insulin sensitivity independent of glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

A model of the kinetics of insulin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

Glucose disposal during insulinopenia in somatostatin-treated dogs. The roles of glucose and glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1984.247.3.E370

10.1152/AJPENDO.1984.247.3.E370

21 January 2018

Identifiers

DOI

0 references

1 reference

13 February 2018